AQP4 and neuromyelitis optica: The presence of AQP4 antibodies is a core diagnostic indicator with 75% sensitivity and 99% specificity for NMO and is critical for differentiation from multiple sclerosis [1]. Ongoing research into NMO, its disease process, and its variants will likely lead to continuing revisions to the diagnostic criteria [4].